US FTC denies Abbott Laboratories' request to narrow infant formula price collusion probe
( May 24, 2023, 14:37 GMT | Official Statement) -- MLex Summary: The US Federal Trade Commission rejected Abbott Laboratories’ request to narrow the scope of an investigation into potential price coordination of infant formula, saying it will "not create further unmerited delay." Even if Abbott’s "unsubstantiated claim" of "millions of dollars" in additional costs to respond to information requests were accurate, "this would not create an undue burden, especially when weighed against the public need of uprooting potential collusion in the vital and extremely lucrative infant formula market," the agency said in an April 25 order published on its website.See documents below....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.